- 2 resultados
menor preço: € 109.00, preço mais alto: € 173.95, preço médio: € 141.48
1
Encomendar
no/na Indigo.ca
(aproximadamente € 173.95)
EncomendarLink patrocinado

Cancer Pharmacogenetics - nuovo livro

ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… mais…

Custos de envio:mais custos de envio
2
Encomendar
no/na bol.com
€ 109.00
EncomendarLink patrocinado

Springer-Verlag New York Inc.:

Cancer Pharmacogenetics - nuovo livro

2008, ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… mais…

  - Nieuw, Vermoedelijk 4-6 weken Custos de envio:Vermoedelijk 4-6 weken, mais custos de envio bol.com

1Como algumas plataformas não transmitem condições de envio e estas podem depender do país de entrega, do preço de compra, do peso e tamanho do item, de uma possível adesão à plataforma, de uma entrega direta pela plataforma ou através de um fornecedor terceirizado (Marketplace), etc., é possível que os custos de envio indicados pela terralivro não correspondam aos da plataforma ofertante.

Dados bibliográficos do melhor livro correspondente

Pormenores referentes ao livro

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the international HapMap project. Cancer therapy offers an ideal scenario for the integration of pharmacogenetics into clinical practice - often there are multiple treatment options but a finite window of time to select the correct one. The ideal of testing patients for genetic markers for chemotherapy efficacy and/or toxicity is becoming a reality with FDA approved clinical tests and genotype-guided clinical trials. This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice. TOC:A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics

Dados detalhados do livro - Cancer Pharmacogenetics


EAN (ISBN-13): 9780387691336
ISBN (ISBN-10): 0387691332
Ano de publicação: 2008
Editor/Editora: Springer

Livro na base de dados desde 2008-03-03T04:33:19-03:00 (Sao Paulo)
Página de detalhes modificada pela última vez em 2017-02-01T18:28:53-02:00 (Sao Paulo)
Número ISBN/EAN: 0387691332

Número ISBN - Ortografia alternativa:
0-387-69133-2, 978-0-387-69133-6
Ortografia alternativa e termos de pesquisa relacionados:
Título do livro: pharmacogenetics, cancer


Dados da editora

Autor: Sharon Marsh
Título: Cancer Pharmacogenetics
Editora: Springer; Springer US
280 Páginas
Ano de publicação: 2010-06-15
New York; NY; US
Língua: Inglês
112,30 € (DE)
115,45 € (AT)
150,65 CHF (CH)
Not available, publisher indicates OP

BB; Book; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; cancer therapy; genetics; chemotherapy; toxicity; cancer treatment; drug; leukemia; pharmacodynamics; research; pharmacokinetics; clinical trial; cancer; kinetics; B; Cancer Research; Biomedical and Life Sciences; Pharmacology/Toxicology; Health Promotion and Disease Prevention; Epidemiology; Medical Microbiology; Pharmakologie; Public Health und Präventivmedizin; Epidemiologie und medizinische Statistik; Mikrobiologie und Virologie; EA

A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics
This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice.

< Para arquivar...